RESUMEN
The panniculitides remain as one of the most challenging areas for clinicians, as they comprise a heterogeneous group of inflammatory diseases involving the subcutaneous fat with potentially-shared clinical and histopathological features. Clinically, most panniculitides present as red edematous nodules or plaques. Therefore, in addition to a detailed clinical history, a large scalpel biopsy of a recent-stage lesion with adequate representation of the subcutaneous tissue is essential to specific diagnosis and appropriate clinical management. Herein we review the panniculitides of particular interest to the rheumatologist.
Asunto(s)
Paniculitis/patología , Reumatólogos , Síndrome de Behçet/patología , Biopsia/métodos , Eritema Indurado/patología , Eritema Nudoso/patología , Etanercept/efectos adversos , Humanos , Inmunosupresores/efectos adversos , Infecciones/patología , Paniculitis/clasificación , Paniculitis de Lupus Eritematoso/patología , Poliarteritis Nudosa/patología , Grasa Subcutánea/patología , Tejido Subcutáneo/patología , Vasculitis/patologíaRESUMEN
OBJECTIVE: To evaluate prevalence, clinical manifestations, laboratory abnormalities, treatment and outcome in a multicenter cohort of childhood-onset systemic lupus erythematosus (cSLE) patients with and without panniculitis. METHODS: Panniculitis was diagnosed due to painful subcutaneous nodules and/or plaques in deep dermis/subcutaneous tissues and lobular/mixed panniculitis with lymphocytic lobular inflammatory infiltrate in skin biopsy. Statistical analysis was performed using Bonferroni correction(p < 0.004). RESULTS: Panniculitis was observed in 6/847(0.7%) cSLE. Painful subcutaneous erythematosus and indurated nodules were observed in 6/6 panniculitis patients and painful subcutaneous plaques in 4/6. Generalized distribution was evidenced in 3/6 and localized in upper limbs in 2/6 and face in 1/6. Cutaneous hyperpigmentation and/or cutaneous atrophy occurred in 5/6. Histopathology features showed lobular panniculitis without vasculitis in 5/6(one of them had concomitant obliterative vasculopathy due to antiphospholipid syndrome) and panniculitis with vasculitis in 1/6. Comparison between cSLE with panniculitis and 60 cSLE without panniculitis with same disease duration [2.75(0-11.4) vs. 2.83(0-11.8) years,p = 0.297], showed higher frequencies of constitutional involvement (67% vs. 10%,p = 0.003) and leukopenia (67% vs. 7%,p = 0.002). Cutaneous atrophy and hyperpigmentation occurred in 83% of patients. CONCLUSIONS: Panniculitis is a rare skin manifestation of cSLE occurring in the first three years of disease with considerable sequelae. The majority of patients have concomitant mild lupus manifestations.
Asunto(s)
Lupus Eritematoso Sistémico/complicaciones , Paniculitis de Lupus Eritematoso/etiología , Adolescente , Edad de Inicio , Brasil/epidemiología , Niño , Estudios de Cohortes , Femenino , Humanos , Lupus Eritematoso Sistémico/epidemiología , Masculino , Paniculitis de Lupus Eritematoso/tratamiento farmacológico , Paniculitis de Lupus Eritematoso/epidemiología , Paniculitis de Lupus Eritematoso/patología , Prevalencia , Adulto JovenRESUMEN
Abstract Objective: To evaluate prevalence, clinical manifestations, laboratory abnormalities, treatment and outcome in a multicenter cohort of childhood-onset systemic lupus erythematosus (cSLE) patients with and without panniculitis. Methods: Panniculitis was diagnosed due to painful subcutaneous nodules and/or plaques in deep dermis/subcutaneous tissues and lobular/mixed panniculitis with lymphocytic lobular inflammatory infiltrate in skin biopsy. Statistical analysis was performed using Bonferroni correction(p < 0.004). Results: Panniculitis was observed in 6/847(0.7%) cSLE. Painful subcutaneous erythematosus and indurated nodules were observed in 6/6 panniculitis patients and painful subcutaneous plaques in 4/6. Generalized distribution was evidenced in 3/6 and localized in upper limbs in 2/6 and face in 1/6. Cutaneous hyperpigmentation and/or cutaneous atrophy occurred in 5/6. Histopathology features showed lobular panniculitis without vasculitis in 5/6(one of them had concomitant obliterative vasculopathy due to antiphospholipid syndrome) and panniculitis with vasculitis in 1/6. Comparison between cSLE with panniculitis and 60 cSLE without panniculitis with same disease duration [2.75(0-11.4) vs. 2.83(0-11.8) years,p = 0.297], showed higher frequencies of constitutional involvement (67% vs. 10%,p = 0.003) and leukopenia (67% vs. 7%,p = 0.002). Cutaneous atrophy and hyperpigmentation occurred in 83% of patients. Conclusions: Panniculitis is a rare skin manifestation of cSLE occurring in the first three years of disease with considerable sequelae. The majority of patients have concomitant mild lupus manifestations.
Asunto(s)
Adolescente , Niño , Femenino , Humanos , Masculino , Adulto Joven , Paniculitis de Lupus Eritematoso/etiología , Lupus Eritematoso Sistémico/complicaciones , Brasil/epidemiología , Paniculitis de Lupus Eritematoso/patología , Paniculitis de Lupus Eritematoso/tratamiento farmacológico , Paniculitis de Lupus Eritematoso/epidemiología , Prevalencia , Estudios de Cohortes , Edad de Inicio , Lupus Eritematoso Sistémico/epidemiologíaRESUMEN
INTRODUCTION: Lupus erythematosus is a multisystemic disease that is characterized by autoantibody production and immune complex deposition in such tissues as the mucosa, joints, the central nervous system, and skin. Cutaneous lupus erythematosus is categorized as acute, subacute, and chronic. Chronic cutaneous lupus erythematosus comprises discoid lupus erythematosus (DLE) and lupus profundus (LP). AIM: To analyze the expression of proapoptotic molecules in patients with lupus erythematosus discoid and lupus profundus. MATERIAL AND METHODS: Descriptive study, the study groups comprised 10 cases of LP and 10 cases of DLE, and a control. Skin samples of cases and controls were processed for immunohistochemistry and by TUNEL technique. The database and statistical analysis was performed (statistical test X(2)) SPSS (Chicago, IL, USA). RESULTS: Apoptotic features were broadly distributed along the skin biopsies in epidermal keratinocytes as well as at dermis. By immunohistochemistry the expression of Fas receptor and Fas-L was higher in the skin of lupus patients compared with controls. We also noted differences in Fas-L, -Fas, and -Bax proteins expression intensity in discoid lupus erythematosus patients in the epidermis, and hair follicles. CONCLUSIONS: Fas and Fas-L are expressed similarly in LP and DLE.
Asunto(s)
Apoptosis , Lupus Eritematoso Cutáneo/patología , Lupus Eritematoso Discoide/patología , Paniculitis de Lupus Eritematoso/patología , Piel/patología , Biomarcadores/análisis , Biopsia , Estudios de Casos y Controles , Distribución de Chi-Cuadrado , Proteína Ligando Fas/análisis , Humanos , Inmunohistoquímica , Etiquetado Corte-Fin in Situ , Lupus Eritematoso Cutáneo/metabolismo , Lupus Eritematoso Discoide/metabolismo , Paniculitis de Lupus Eritematoso/metabolismo , Piel/química , Proteína X Asociada a bcl-2/análisis , Receptor fas/análisisRESUMEN
Wound repair is a complex process that involves inflammation, proliferation, extracellular matrix deposition/remodeling and apoptosis. Autoimmune diseases profoundly affect the healing process. We have used histological parameters to characterize the recruitment of mast cells and the proliferative activity and apoptosis in the fibrovascular tissue induced by subcutaneous polyether-polyurethane sponge implants in lupus-prone New Zealand White (NZW) and in control Balb/c mouse strains at days 10 and 21 post implantation. Fibrovascular tissue infiltration (hematoxylin and eosin staining), mast cell number (Dominici staining) and cellular proliferation (AgNOR staining) peaked early (day 10) but collagen deposition (picrosirius red staining) and apoptosis remained high in implants of NZW mice during the experimental period. In contrast, implants of Balb/c animals showed a progressive increase in mast cell recruitment and cellular proliferation but apoptosis fell from day 10 to 21 post-implantation. This divergent response early mast cells recruitment, excessive collagen deposition and disturbed removal of apoptotic cells from the site of injury in NZW mice implies that the genotype trait of NZW mice is a determining factor in abnormal healing response.
Asunto(s)
Apoptosis/fisiología , Reacción a Cuerpo Extraño/patología , Implantes Experimentales/efectos adversos , Lupus Eritematoso Sistémico/patología , Paniculitis de Lupus Eritematoso/patología , Animales , Antígenos Nucleares/fisiología , Proliferación Celular , Colágeno/metabolismo , Modelos Animales de Enfermedad , Reacción a Cuerpo Extraño/inmunología , Reacción a Cuerpo Extraño/metabolismo , Lupus Eritematoso Sistémico/inmunología , Lupus Eritematoso Sistémico/metabolismo , Masculino , Mastocitos/patología , Ratones , Ratones Endogámicos BALB C , Paniculitis de Lupus Eritematoso/inmunología , Paniculitis de Lupus Eritematoso/metabolismo , Especificidad de la Especie , Cicatrización de Heridas/inmunologíaRESUMEN
La Paniculitis Lúpica es un proceso inflamatorio crónico y recurrente del tejido adiposo subcutaneo, en forma de nódulos o placas induradas, asociado o no manifestaciones cutáneas o sistémicas del lupus eritematoso, con histopatología característica. Presentamos el caso de una paciente mujer sin antecedente de lupus eritematoso, con paniculitis extensa de pared abdominal asociada a dolor que llevan a postración y con signos de lupus sistémico.
Lupus panniculitis is an inflammatory, chronic and recurrent process of the subcutaneous fat tissue in form of nodules or indurates plaques, associated or not to cutaneous or systemic manifestations of lupus erythematosus, with relatively characteristic histopathology. We present the case of a woman patient without antecedent of lupus erythematosus, with widespread panniculitis of abdominal wall associated to pain that take to prostration and with signs of systemic lupus.
Asunto(s)
Humanos , Femenino , Adulto , Paniculitis de Lupus Eritematoso/diagnóstico , Paniculitis de Lupus Eritematoso/patología , Paniculitis de Lupus Eritematoso/terapiaRESUMEN
La paniculitis lúpica (PL) es una entidad benigna. Según nuestra investigación, la PL no ha sido comunicada en la literatura radiológica. A diferencia de artículos previos que no han sido enfocados en métodos de diagnóstico por imágenes, nuestro objetivo es describir los hallazgos imagenológicos. TC y RM permiten demostrar la lipoatrofia y las áreas de actividad inflamatoria en el tejido subcutáneo (AU)
Asunto(s)
Humanos , Femenino , Adulto , Paniculitis de Lupus Eritematoso/diagnóstico , Paniculitis de Lupus Eritematoso/epidemiología , Paniculitis de Lupus Eritematoso/patología , Imagen por Resonancia Magnética , Espectroscopía de Resonancia Magnética/diagnósticoRESUMEN
The second part of our review of panniculitis summarizes the clinicopathologic features of the mostly lobular panniculitides. Erythema induratum of Bazin (nodular vasculitis) represents the most common variant of lobular panniculitis with vasculitis, although controversy persists about the nature of the involved vessels. Mostly lobular panniculitides without vasculitis comprise a series of disparate disorders. These include sclerosing panniculitis that results from chronic venous insufficiency of the lower extremities; panniculitis with calcification of the vessel walls such as calciphylaxis and oxalosis; and inflammatory diseases with crystals within the adipocytes such as sclerema neonatorum, subcutaneous fat necrosis of the newborn, and poststeroid panniculitis. Connective tissue diseases, such as systemic lupus erythematosus and dermatomyositis, pancreatic diseases, and alpha(1)-antitrypsin deficiency may also show a mostly lobular panniculitis with characteristic histopathologic features. Lobular panniculitis may also be an expression of infections, trauma, or factitial causes involving the subcutaneous fat. Lipoatrophy refers to a loss of subcutaneous fat due to a previous inflammatory process involving the subcutis, and it may be the late-stage lesion of several types of panniculitis. In contrast, lipodystrophy means an absence of subcutaneous fat with no evidence of inflammation and often the process is associated with endocrinologic, metabolic, or autoimmune diseases. Finally, cytophagic histiocytic panniculitis is the term that has been used to describe two different processes: one is inflammatory, a lobular panniculitis, and the other one is neoplastic, a subcutaneous T-cell lymphoma. The only common feature of these two different processes is the presence of cytophagocytosis in the lesions. (J Am Acad Dermatol 2001;45:325-61.) Learning objective: At the completion of this learning activity, participants should be familiar with the pathogenesis, clinical manifestations, histopathologic findings, and treatment options for the most frequent variants of the lobular panniculitides.
Asunto(s)
Humanos , Deficiencia de alfa 1-Antitripsina/complicaciones , Deficiencia de alfa 1-Antitripsina/patología , Enfermedades Cutáneas Infecciosas/complicaciones , Enfermedades Cutáneas Infecciosas/patología , Paniculitis Nodular no Supurativa/complicaciones , Paniculitis Nodular no Supurativa/patología , Paniculitis de Lupus Eritematoso/complicaciones , Paniculitis de Lupus Eritematoso/patología , Paniculitis/clasificación , Paniculitis/complicaciones , Paniculitis/patología , Piel/lesiones , Piel/patología , Sarcoidosis/complicaciones , Sarcoidosis/patologíaRESUMEN
Breast and nipple skin is commonly affected by various inflammatory and neoplastic processes. Despite this fact, many physicians are unaware of the spectrum of diseases that can involve this area. Because breast and nipple skin represents a cosmetically, sexually, and functionally important entity to most patients, awareness of these disease entities is invaluable. This article reviews the normal anatomy of the breast, cutaneous manifestations of neoplastic processes that can present in these areas, and common inflammatory diseases of the breast and nipple skin.
Asunto(s)
Femenino , Humanos , Anticoagulantes/efectos adversos , Dermatitis/diagnóstico , Dermatitis/etiología , Dermatitis/patología , Enfermedades de la Mama/diagnóstico , Enfermedades de la Mama/etiología , Enfermedades de la Mama/patología , Esclerodermia Localizada/patología , Hidradenitis Supurativa/patología , Pezones/patología , Mastitis/patología , Necrosis , Neoplasias de la Mama/complicaciones , Paniculitis de Lupus Eritematoso/patología , Warfarina/efectos adversosRESUMEN
La piel está comprometida en la mayoría de los pacientes con lupus eritematoso. Las lesiones cutáneas más frecuentes son el rash malar, la fotosensibilidad, la alopecia, lupus discoide, lesiones en mucosas, pigmentación, vasculitis, fenómeno de Raynaud y urticaria. Menos frecuentemente los pacientes con lupus pueden desarrollar variantes clínicas inusuales tales como lupus eritematoso ampollar, lupus pernio, lupus eritematoso simil eritema gyrate y lesiones simil-eritema multiforme (síndrome de Rowell). Presentamos cinco pacientes con estas manifestaciones poco frecuentes. El reconocimiento de esta presentación es necesaria para un diagnóstico y tratamiento precoz y adecuado (AU)
Asunto(s)
Humanos , Femenino , Adolescente , Adulto , Lupus Eritematoso Sistémico/diagnóstico , Lupus Eritematoso Cutáneo/diagnóstico , Lupus Eritematoso Sistémico/clasificación , Lupus Eritematoso Sistémico/patología , Lupus Eritematoso Cutáneo/clasificación , Paniculitis de Lupus Eritematoso/patología , Paniculitis de Lupus Eritematoso/tratamiento farmacológico , Eritema Pernio/fisiopatologíaRESUMEN
La piel está comprometida en la mayoría de los pacientes con lupus eritematoso. Las lesiones cutáneas más frecuentes son el rash malar, la fotosensibilidad, la alopecia, lupus discoide, lesiones en mucosas, pigmentación, vasculitis, fenómeno de Raynaud y urticaria. Menos frecuentemente los pacientes con lupus pueden desarrollar variantes clínicas inusuales tales como lupus eritematoso ampollar, lupus pernio, lupus eritematoso simil eritema gyrate y lesiones simil-eritema multiforme (síndrome de Rowell). Presentamos cinco pacientes con estas manifestaciones poco frecuentes. El reconocimiento de esta presentación es necesaria para un diagnóstico y tratamiento precoz y adecuado